Amy E. DeClue

2.1k total citations
80 papers, 1.4k citations indexed

About

Amy E. DeClue is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Physiology. According to data from OpenAlex, Amy E. DeClue has authored 80 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 25 papers in Immunology and 22 papers in Physiology. Recurrent topics in Amy E. DeClue's work include Immune Response and Inflammation (22 papers), Asthma and respiratory diseases (18 papers) and Veterinary Oncology Research (14 papers). Amy E. DeClue is often cited by papers focused on Immune Response and Inflammation (22 papers), Asthma and respiratory diseases (18 papers) and Veterinary Oncology Research (14 papers). Amy E. DeClue collaborates with scholars based in United States, Hungary and Netherlands. Amy E. DeClue's co-authors include Carol R. Reinero, Leah A. Cohn, Marie E. Kerl, John R. Dodam, Claire R. Sharp, Jared A. Jaffey, Tekla M. Lee‐Fowler, Charles E. Wiedmeyer, Sandra M. Axiak‐Bechtel and Christine Spinka and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Critical Care Medicine.

In The Last Decade

Amy E. DeClue

79 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. DeClue United States 23 419 300 260 231 230 80 1.4k
Daniel L. Chan United Kingdom 27 357 0.9× 185 0.6× 116 0.4× 126 0.5× 330 1.4× 79 1.7k
Paulina Sannomiya Brazil 27 287 0.7× 319 1.1× 471 1.8× 229 1.0× 38 0.2× 81 2.0k
Tatsuhiro Masaoka Japan 27 355 0.8× 323 1.1× 154 0.6× 108 0.5× 252 1.1× 116 2.5k
Kurt J. Williams United States 23 758 1.8× 181 0.6× 185 0.7× 39 0.2× 88 0.4× 68 1.9k
Ahmet Gödekmerdan Türkiye 23 177 0.4× 123 0.4× 314 1.2× 64 0.3× 92 0.4× 67 1.4k
Robert J. Washabau United States 29 543 1.3× 253 0.8× 111 0.4× 65 0.3× 447 1.9× 67 2.3k
Alice Schmidt Austria 27 227 0.5× 274 0.9× 139 0.5× 279 1.2× 251 1.1× 90 2.2k
Thomas K. Graves United States 23 169 0.4× 176 0.6× 43 0.2× 444 1.9× 593 2.6× 60 1.4k
Andreas Lun Germany 23 139 0.3× 250 0.8× 217 0.8× 83 0.4× 46 0.2× 64 1.6k
Eric V. Granowitz United States 17 159 0.4× 147 0.5× 880 3.4× 126 0.5× 64 0.3× 25 2.0k

Countries citing papers authored by Amy E. DeClue

Since Specialization
Citations

This map shows the geographic impact of Amy E. DeClue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. DeClue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. DeClue more than expected).

Fields of papers citing papers by Amy E. DeClue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. DeClue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. DeClue. The network helps show where Amy E. DeClue may publish in the future.

Co-authorship network of co-authors of Amy E. DeClue

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. DeClue. A scholar is included among the top collaborators of Amy E. DeClue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. DeClue. Amy E. DeClue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeClue, Amy E., Massimo Giunti, Robert Goggs, et al.. (2024). Defining sepsis in small animals. Journal of Veterinary Emergency and Critical Care. 34(2). 97–109. 9 indexed citations
2.
DeClue, Amy E., et al.. (2020). Transportation and Routine Veterinary Interventions Alter Immune Function in the Dog. Topics in companion animal medicine. 39. 100408–100408. 3 indexed citations
3.
Jaffey, Jared A., et al.. (2018). Serum vitamin D concentrations in hospitalized critically ill dogs. PLoS ONE. 13(3). e0194062–e0194062. 26 indexed citations
4.
DeClue, Amy E., Sandra M. Axiak‐Bechtel, Yan Zhang, et al.. (2018). Identification of immunologic and clinical characteristics that predict inflammatory response to C. Novyi-NT bacteriolytic immunotherapy. BMC Veterinary Research. 14(1). 119–119. 3 indexed citations
5.
DeClue, Amy E., Sandra M. Axiak‐Bechtel, Yan Zhang, et al.. (2018). Immune response to C. novyi-NT immunotherapy. Veterinary Research. 49(1). 38–38. 19 indexed citations
6.
Axiak‐Bechtel, Sandra M., et al.. (2018). Resveratrol administration increases phagocytosis, decreases oxidative burst, and promotes pro-inflammatory cytokine production in healthy dogs. Veterinary Immunology and Immunopathology. 203. 21–29. 8 indexed citations
7.
Jaffey, Jared A., et al.. (2017). Desoxycorticosterone Pivalate Duration of Action and Individualized Dosing Intervals in Dogs with Primary Hypoadrenocorticism. Journal of Veterinary Internal Medicine. 31(6). 1649–1657. 13 indexed citations
8.
DeClue, Amy E., et al.. (2017). Immune Function in Critically Ill Dogs. Journal of Veterinary Internal Medicine. 32(1). 208–216. 10 indexed citations
9.
Dodam, John R., et al.. (2015). Morphine and buprenorphine do not alter leukocyte cytokine production capacity, early apoptosis, or neutrophil phagocytic function in healthy dogs. Research in Veterinary Science. 99. 70–76. 6 indexed citations
10.
11.
Axiak‐Bechtel, Sandra M., et al.. (2014). Resveratrol decreases oxidative burst capacity and alters stimulated leukocyte cytokine production in vitro. Veterinary Immunology and Immunopathology. 163(3-4). 164–173. 12 indexed citations
12.
Axiak‐Bechtel, Sandra M., et al.. (2014). Effects of tramadol and o-desmethyltramadol on canine innate immune system function. Veterinary Anaesthesia and Analgesia. 42(3). 260–268. 14 indexed citations
13.
Axiak‐Bechtel, Sandra M., et al.. (2012). Effect of opioids on CXCL-8 production in healthy cats. Research in Veterinary Science. 93(3). 1255–1257. 3 indexed citations
14.
Lee‐Fowler, Tekla M., Vamsi P. Guntur, John R. Dodam, et al.. (2012). The Tyrosine Kinase Inhibitor Masitinib Blunts Airway Inflammation and Improves Associated Lung Mechanics in a Feline Model of Chronic Allergic Asthma. International Archives of Allergy and Immunology. 158(4). 369–374. 31 indexed citations
15.
DeClue, Amy E., et al.. (2010). Pathogen associated molecular pattern-induced TNF, IL-1β, IL-6 and CXCL-8 production from feline whole blood culture. Research in Veterinary Science. 90(1). 59–63. 14 indexed citations
16.
Lee‐Fowler, Tekla M., et al.. (2009). Comparison of intradermal skin testing (IDST) and serum allergen-specific IgE determination in an experimental model of feline asthma. Veterinary Immunology and Immunopathology. 132(1). 46–52. 28 indexed citations
17.
Reinero, Carol R., Amy E. DeClue, & Peter Rabinowitz. (2009). Asthma in humans and cats: Is there a common sensitivity to aeroallegens in shared environments?. Environmental Research. 109(5). 634–640. 31 indexed citations
18.
DeClue, Amy E., et al.. (2009). Systemic response to low-dose endotoxin infusion in cats. Veterinary Immunology and Immunopathology. 132(2-4). 167–174. 21 indexed citations
19.
Reinero, Carol R., et al.. (2007). Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma. Veterinary Immunology and Immunopathology. 121(3-4). 241–250. 35 indexed citations
20.
DeClue, Amy E., Leah A. Cohn, Marie E. Kerl, & Charles E. Wiedmeyer. (2004). Use of Continuous Blood Glucose Monitoring for Animals With Diabetes Mellitus. Journal of the American Animal Hospital Association. 40(3). 171–173. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel L. Chan Breakdown of academic impact, for papers by Paulina Sannomiya Breakdown of academic impact, for papers by Tatsuhiro Masaoka Breakdown of academic impact, for papers by Kurt J. Williams Breakdown of academic impact, for papers by Ahmet Gödekmerdan Breakdown of academic impact, for papers by Robert J. Washabau Breakdown of academic impact, for papers by Alice Schmidt Breakdown of academic impact, for papers by Thomas K. Graves Breakdown of academic impact, for papers by Andreas Lun Breakdown of academic impact, for papers by Eric V. Granowitz
Rankless by CCL
2026